aeris Capital Equity Investments, L.P.
Insider CIK 1605431 · ADMS 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ADMS Adamas Pharmaceuticals Inc | S Sale | 2015-03-13 | 2015-03-17 | 350,000 | $17.23 | $6.03M | 1,662,128 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | S Sale | 2014-12-03 | 2014-12-04 | 105,225 | $14.51 | $1.53M | 2,012,128 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | S Sale | 2014-12-02 | 2014-12-04 | 6,400 | $14.51 | $92.9K | 2,117,353 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | S Sale | 2014-12-01 | 2014-12-02 | 12,815 | $14.51 | $185.9K | 2,123,753 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | S Sale | 2014-11-28 | 2014-12-02 | 800 | $14.93 | $11.9K | 2,136,568 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | S Sale | 2014-11-26 | 2014-11-28 | 12,500 | $14.77 | $184.6K | 2,137,368 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | S Sale | 2014-11-25 | 2014-11-26 | 5,600 | $14.85 | $83.2K | 2,149,868 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | S Sale | 2014-11-24 | 2014-11-26 | 4,400 | $14.86 | $65.4K | 2,155,468 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | S Sale | 2014-11-21 | 2014-11-25 | 8,760 | $14.82 | $129.8K | 2,159,868 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | S Sale | 2014-11-20 | 2014-11-24 | 3,500 | $14.69 | $51.4K | 2,168,628 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | X Exercise deriv | 2014-04-15 | 2014-04-15 | 80,418 | — | $0 | 0 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | X Exercise deriv | 2014-04-15 | 2014-04-15 | 3,980 | — | $0 | 0 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | X Exercise deriv | 2014-04-15 | 2014-04-15 | 8,814 | — | $0 | 0 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | X Exercise deriv | 2014-04-15 | 2014-04-15 | 10,017 | — | $0 | 0 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | X Exercise deriv | 2014-04-15 | 2014-04-15 | 4,265 | — | $0 | 0 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | X Exercise deriv | 2014-04-15 | 2014-04-15 | 4,265 | — | $0 | 0 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | X Exercise deriv | 2014-04-15 | 2014-04-15 | 4,265 | — | $0 | 0 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | X Exercise deriv | 2014-04-15 | 2014-04-15 | 4,265 | — | $0 | 0 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | C Conversion deriv | 2014-04-15 | 2014-04-15 | 300 | — | $0 | 0 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | C Conversion deriv | 2014-04-15 | 2014-04-15 | 979,742 | — | $0 | 0 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | X Exercise deriv | 2014-04-15 | 2014-04-15 | 4,265 | — | $0 | 0 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | C Conversion | 2014-04-15 | 2014-04-15 | 1,104,596 | — | $0 | 2,172,128 | SEC↗ |